Literature DB >> 18286534

Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?

Isabelle de Mascarel1, Gaetan MacGrogan, Marc Debled, Veronique Brouste, Louis Mauriac.   

Abstract

BACKGROUND: In routine practice, the distinction between isolated tumor cells (ITC) and micrometastases (MIC) in patients with breast cancer is sometimes difficult to discern. The authors assessed differences in classifying patients according to the American Joint Commission on Cancer (AJCC) and the International Union Against Cancer (UICC) definitions and method of sizing.
METHODS: We assessed the characteristics of metastatic deposits in only 1 involved lymph node in 337 patients with operable breast cancer (median follow-up, 15.3 years). When sizing multiple clusters, either the diameter of the area with close clusters (Method 1) or the size of the largest cluster (Method 2) was taken into account. Patients were classified and their survival was assessed according to the 2 sizing methods and the criteria used for definitions (size in AJCC; size and topography in UICC).
RESULTS: With the AJCC definitions, 32 patients would be differently classified according to the method of sizing. With the UICC definitions, some patients with parenchymal ITC would be classified as pN1mi, 38 by Method 1 and 53 by Method 2. Some pathologists would classify the 66 patients who had isolated capsular vascular invasion as pN0. Classification was uncertain in 136 (40%) to 151 (45 %) patients. Survival was not significantly different between pN0(i+) and pN1(mi) patients.
CONCLUSIONS: The distinction between ITC and MIC was often difficult and without any prognostic significance. Precise guidelines are more useful for staging than for therapy. Thus, complete axillary dissection is usually performed in pN0(i+) and pN1(mi) patients, whereas chemotherapy is not indicated or debatable when MIC is the only 1 pejorative criterion.

Entities:  

Mesh:

Year:  2008        PMID: 18286534     DOI: 10.1002/cncr.23368

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Regional Disease Control in Selected Patients with Sentinel Lymph Node Involvement and Omission of Axillary Lymph Node Dissection.

Authors:  Gábor Cserni; Róbert Maráz
Journal:  Pathol Oncol Res       Date:  2015-02-04       Impact factor: 3.201

2.  The prognostic significance of isolated tumor cells in the lymph nodes of gastric cancer patients.

Authors:  Takeo Fukagawa; Mitsuru Sasako; Seiji Ito; Hayao Nakanishi; Hisae Iinuma; Shoji Natsugoe; Hitoshi Katai; Tadakazu Shimoda
Journal:  Gastric Cancer       Date:  2010-09-05       Impact factor: 7.370

3.  Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population?

Authors:  Oldrich Coufal; Tomás Pavlík; Pavel Fabian; Rita Bori; Gábor Boross; István Sejben; Róbert Maráz; Jaroslav Koca; Eva Krejcí; Iva Horáková; Vendula Foltinová; Pavlína Vrtelová; Vojtech Chrenko; Wolde Eliza Tekle; Mária Rajtár; Mihály Svébis; Vuk Fait; Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2009-05-15       Impact factor: 3.201

4.  Patients' choice on axillary lymph node dissection following sentinel lymph node micrometastasis--first report on prospective use of a nomogram in very low risk patients.

Authors:  Gábor Cserni; Istvánné Bezsenyi; László Markó
Journal:  Pathol Oncol Res       Date:  2012-10-16       Impact factor: 3.201

Review 5.  [Sentinel node biopsy in breast cancer: pathological analysis and interpretation].

Authors:  G Cserni; T Decker
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

Review 6.  The new TNM-based staging of breast cancer.

Authors:  Gábor Cserni; Ewa Chmielik; Bálint Cserni; Tibor Tot
Journal:  Virchows Arch       Date:  2018-01-27       Impact factor: 4.064

Review 7.  Sentinel lymph node assessment in breast cancer-an update on current recommendations.

Authors:  Gábor Cserni; Aoife Maguire; Simonetta Bianchi; Ales Ryska; Anikó Kovács
Journal:  Virchows Arch       Date:  2021-06-23       Impact factor: 4.064

Review 8.  Sentinel Lymph Node in Breast Cancer: Review Article from a Pathologist's Point of View.

Authors:  Sophia K Apple
Journal:  J Pathol Transl Med       Date:  2016-01-12

9.  Does the Presence of Cytokeratin Positive Individual Tumor Cells (N0(I+)) in Sentinel Lymph Nodes Affect Clinical Outcomes in Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation.

Authors:  Jamie Smith; Charles Leonard; Dennis L Carter; Shannon Tole
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-08-29

10.  Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes.

Authors:  Inne J Den Toom; Elisabeth Bloemena; Stijn van Weert; K Hakki Karagozoglu; Otto S Hoekstra; Remco de Bree
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-25       Impact factor: 2.503

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.